Literature DB >> 19297321

Hepatitis C virus NS5A protein is a substrate for the peptidyl-prolyl cis/trans isomerase activity of cyclophilins A and B.

Xavier Hanoulle1, Aurélie Badillo2, Jean-Michel Wieruszeski1, Dries Verdegem1, Isabelle Landrieu1, Ralf Bartenschlager3, François Penin2, Guy Lippens4.   

Abstract

We report here a biochemical and structural characterization of domain 2 of the nonstructural 5A protein (NS5A) from the JFH1 Hepatitis C virus strain and its interactions with cyclophilins A and B (CypA and CypB). Gel filtration chromatography, circular dichroism spectroscopy, and finally NMR spectroscopy all indicate the natively unfolded nature of this NS5A-D2 domain. Because mutations in this domain have been linked to cyclosporin A resistance, we used NMR spectroscopy to investigate potential interactions between NS5A-D2 and cellular CypA and CypB. We observed a direct molecular interaction between NS5A-D2 and both cyclophilins. The interaction surface on the cyclophilins corresponds to their active site, whereas on NS5A-D2, it proved to be distributed over the many proline residues of the domain. NMR heteronuclear exchange spectroscopy yielded direct evidence that many proline residues in NS5A-D2 form a valid substrate for the enzymatic peptidyl-prolyl cis/trans isomerase (PPIase) activity of CypA and CypB.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19297321      PMCID: PMC2679460          DOI: 10.1074/jbc.M809244200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  69 in total

1.  Molecular recognition in the HIV-1 capsid/cyclophilin A complex.

Authors:  S Yoo; D G Myszka; C Yeh; M McMurray; C P Hill; W I Sundquist
Journal:  J Mol Biol       Date:  1997-06-27       Impact factor: 5.469

Review 2.  Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection.

Authors:  Jeremy Luban
Journal:  J Virol       Date:  2006-09-06       Impact factor: 5.103

Review 3.  Intrinsically unstructured proteins and their functions.

Authors:  H Jane Dyson; Peter E Wright
Journal:  Nat Rev Mol Cell Biol       Date:  2005-03       Impact factor: 94.444

4.  Structure of the Threonine-Rich Extensin from Zea mays.

Authors:  M J Kieliszewski; J F Leykam; D T Lamport
Journal:  Plant Physiol       Date:  1990-02       Impact factor: 8.340

5.  Diverse effects of cyclosporine on hepatitis C virus strain replication.

Authors:  Naoto Ishii; Koichi Watashi; Takayuki Hishiki; Kaku Goto; Daisuke Inoue; Makoto Hijikata; Takaji Wakita; Nobuyuki Kato; Kunitada Shimotohno
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

6.  The cyclophilin multigene family of peptidyl-prolyl isomerases. Characterization of three separate human isoforms.

Authors:  D J Bergsma; C Eder; M Gross; H Kersten; D Sylvester; E Appelbaum; D Cusimano; G P Livi; M M McLaughlin; K Kasyan
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

7.  An amino-terminal amphipathic alpha-helix mediates membrane association of the hepatitis C virus nonstructural protein 5A.

Authors:  Volker Brass; Elke Bieck; Roland Montserret; Benno Wölk; Jan Albert Hellings; Hubert E Blum; François Penin; Darius Moradpour
Journal:  J Biol Chem       Date:  2001-12-14       Impact factor: 5.157

8.  Cyclophilin and viruses: cyclophilin as a cofactor for viral infection and possible anti-viral target.

Authors:  Koichi Watashi; Kunitada Shimotohno
Journal:  Drug Target Insights       Date:  2007-02-05

9.  Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein.

Authors:  Timothy L Tellinghuisen; Katie L Foss; Jason C Treadaway; Charles M Rice
Journal:  J Virol       Date:  2007-11-21       Impact factor: 5.103

Review 10.  Hepatitis C virus NS5A: tales of a promiscuous protein.

Authors:  Andrew Macdonald; Mark Harris
Journal:  J Gen Virol       Date:  2004-09       Impact factor: 3.891

View more
  81 in total

Review 1.  Anti-HCV drugs in the pipeline.

Authors:  Priscilla L Yang; Min Gao; Kai Lin; Qingsong Liu; Valerie A Villareal
Journal:  Curr Opin Virol       Date:  2011-11-13       Impact factor: 7.090

2.  Identification of Conus peptidylprolyl cis-trans isomerases (PPIases) and assessment of their role in the oxidative folding of conotoxins.

Authors:  Helena Safavi-Hemami; Grzegorz Bulaj; Baldomero M Olivera; Nicholas A Williamson; Anthony W Purcell
Journal:  J Biol Chem       Date:  2010-02-10       Impact factor: 5.157

Review 3.  Chaperones in hepatitis C virus infection.

Authors:  Ronik Khachatoorian; Samuel W French
Journal:  World J Hepatol       Date:  2016-01-08

4.  Intrinsic disorder mediates hepatitis C virus core-host cell protein interactions.

Authors:  Patrick T Dolan; Andrew P Roth; Bin Xue; Ren Sun; A Keith Dunker; Vladimir N Uversky; Douglas J LaCount
Journal:  Protein Sci       Date:  2014-12-31       Impact factor: 6.725

Review 5.  Host-targeting agents in the treatment of hepatitis C: a beginning and an end?

Authors:  James M Baugh; Jose A Garcia-Rivera; Philippe A Gallay
Journal:  Antiviral Res       Date:  2013-09-30       Impact factor: 5.970

6.  DEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5A.

Authors:  Lotte Coelmont; Xavier Hanoulle; Udayan Chatterji; Carola Berger; Joke Snoeck; Michael Bobardt; Precious Lim; Inge Vliegen; Jan Paeshuyse; Grégoire Vuagniaux; Anne-Mieke Vandamme; Ralf Bartenschlager; Philippe Gallay; Guy Lippens; Johan Neyts
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

7.  A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approach.

Authors:  Feng Yang; Jason M Robotham; Henry Grise; Stephen Frausto; Vanesa Madan; Margarita Zayas; Ralf Bartenschlager; Margaret Robinson; Andrew E Greenstein; Anita Nag; Timothy M Logan; Ewa Bienkiewicz; Hengli Tang
Journal:  PLoS Pathog       Date:  2010-09-23       Impact factor: 6.823

8.  TARGETING THE NS5A PROTEIN OF HCV: AN EMERGING OPTION.

Authors:  D G Cordek; J T Bechtel; A T Maynard; W M Kazmierski; C E Cameron
Journal:  Drugs Future       Date:  2011-09       Impact factor: 0.148

9.  Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics.

Authors:  Artur Kaul; Sarah Stauffer; Carola Berger; Thomas Pertel; Jennifer Schmitt; Stephanie Kallis; Margarita Zayas; Margarita Zayas Lopez; Volker Lohmann; Jeremy Luban; Ralf Bartenschlager
Journal:  PLoS Pathog       Date:  2009-08-14       Impact factor: 6.823

10.  Cyclosporine inhibits a direct interaction between cyclophilins and hepatitis C NS5A.

Authors:  Fiona Fernandes; Israr-ul H Ansari; Rob Striker
Journal:  PLoS One       Date:  2010-03-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.